SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-069269
Filing Date
2021-03-04
Accepted
2021-03-04 14:25:35
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d125275ds3.htm S-3 166508
2 EX-4.5 d125275dex45.htm EX-4.5 423240
3 EX-5.1 d125275dex51.htm EX-5.1 20207
4 EX-23.2 d125275dex232.htm EX-23.2 1705
5 GRAPHIC g125275g0303111129181.jpg GRAPHIC 2357
6 GRAPHIC g125275g15c22.jpg GRAPHIC 31349
  Complete submission text file 0001193125-21-069269.txt   655804
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-253874 | Film No.: 21713660
SIC: 2834 Pharmaceutical Preparations